Leukocyte differential gene expression prognostic value for high versus low seizure frequency in temporal lobe epilepsy.
Ryan SprisslerMichael HammerDavid LabinerNeil JoshiAlbert AlanMartin WeinandPublished in: BMC neurology (2024)
Low and high seizure frequency TLE are predicted by the respective upregulation and downregulation of specific leukocyte genes involved in canonical pathways of neuroinflammation, oxidative stress and lipid peroxidation, GABA (γ-aminobutyric acid) inhibition, and AMPA and NMDA receptor signaling. Furthermore, high seizure frequency-TLE is distinguished prognostically from low seizure frequency-TLE by differentially increased specific leukocyte gene expression involved in GABA inhibition and NMDA receptor signaling. High and low seizure frequency patients appear to represent two mechanistically different forms of temporal lobe epilepsy based on leukocyte gene expression.
Keyphrases
- temporal lobe epilepsy
- gene expression
- dna methylation
- oxidative stress
- end stage renal disease
- cell proliferation
- traumatic brain injury
- signaling pathway
- chronic kidney disease
- newly diagnosed
- lipopolysaccharide induced
- inflammatory response
- ischemia reperfusion injury
- fatty acid
- lps induced
- induced apoptosis
- heat shock protein